Bryan Kraus
About Bryan Kraus
Bryan Kraus is the Director of US Strategic Payer Marketing - Immunology at Bristol Myers Squibb in Lawrenceville, NJ, with extensive experience in managed care contracting and market access strategy.
Title at Bristol Myers Squibb
Bryan Kraus serves as Director of US Strategic Payer Marketing for the Immunology division at Bristol Myers Squibb. He is currently based in Lawrenceville, NJ. In this role, he oversees the development and execution of strategies for payer marketing in the immunology sector.
Previous Roles at Bristol Myers Squibb
Bryan Kraus has previously held several critical positions at Bristol Myers Squibb. These include Senior Product Manager for Eliquis Professional Marketing from 2018 to 2020, and Associate Director for Eliquis Payer Marketing from 2015 to 2018. His earlier roles include Associate Director for Pricing & Economics, Manager for Managed Care Contract Operations, and Associate Manager for Institutional Contract Operations.
Education and Expertise
Bryan Kraus earned an MBA in Finance from Rider University between 2004 and 2006. Prior to that, he completed a BS in Business Administration with a focus on Information Systems Management from The College of New Jersey, graduating in 2002. His educational background has provided a strong foundation for his extensive career in pharmaceutical marketing and management.
Background in Managed Care and Government Pricing
Bryan Kraus has a robust background in managed care contracting and government pricing. This includes experience with AMP, BP, and ASP. He has also led access and reimbursement strategy for medications like Orencia, used to treat rheumatoid arthritis. His expertise extends to tactical execution for US access planning within the immunology portfolio at Bristol Myers Squibb.
Professional and Payer Marketing Experience
Over his career, Bryan Kraus has held multiple roles with increasing responsibility in professional and payer marketing, as well as market access strategy. His specialization in institutional and group purchasing organization contracting positions him as a valuable asset in navigating complex market dynamics and ensuring optimal access to crucial medications.